Clinical trial
Effects of Nattokinase on Inflammation and Cardiovascular Risk Markers in Patients With Dyslipidemia
NCT06183307 is registered in ClinicalTrials.gov with Universidade Federal Fluminense as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Nattokinase on Inflammation and Cardiovascular Risk Markers in Patients With Dyslipidemia
- Lead sponsor
- Universidade Federal Fluminense
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- August 3, 2024
- Completion date
- December 20, 2026
- Enrollment
- 48 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.